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Cognitive impairment is very frequent during multiple sclerosis (MS), involving approximately 40–70% of the
patients, with a profound impact on patient’s life. It is now established that among the various central nervous
system (CNS) structures involved during the course of MS, the hippocampus is particularly sensitive to the
detrimental effects of neuroinflammation. Different studies demonstrated hippocampal involvement during MS,
in association with depression and cognitive impairment, such as verbal and visuo-spatial memory deficits, even
during the earlier phases of the disease. These cognitive alterations could represent the visible consequences of a
hidden synaptic impairment. Indeed, neuronal and immune functions are intertwined and the immune system is
able to modulate the efficacy of synaptic transmission and the induction of the main forms of synaptic plasticity,
such as long term potentiation (LTP). Hippocampal synaptic plasticity has been studied during the last decades as
the physiological basis of human learning and memory and its disruption can be associated with behavioral and
cognitive abnormalities. The aim of the present work is to review the available evidence about the presence of
hippocampal synaptic plasticity alterations in experimental models of MS, specifically during the course of
experimental autoimmune encephalomyelitis (EAE) and to discuss their relevance with regard to human MS.
Indeed, the failure of synapses to express plasticity during neuroinflammation could potentially lead to a
progressive failure of the brain plastic reserve, possibly contributing to disability progression and cognitive
impairment during MS.
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Neurons and synapses are located behind the blood–
brain barrier and the anatomical and functional char-
acteristics of cerebral perfusion led to the erroneous
believing that the physiology of neuronal communica-
tion could not be influenced by immune responses.
Conversely, it is now well established that neuronal
function is strongly influenced by both central and
peripheral inflammation [1]. In particular, it has been
shown that the immune system is able to modulate* Correspondence: massimiliano.difilippo@unipg.it
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the main forms of synaptic plasticity [1]. Glial and micro-
glial cells are now recognized as active elements of
synapses, playing a central role in neuro-inflammatory
processes [2–4]. Moreover, several soluble products that
were thought to exclusively exert immunological func-
tions, such as cytokines, are known to influence synaptic
transmission during both physiological and pathological
conditions [1, 5]. In particular, the inflammatory demye-
linating process taking place during multiple sclerosis
(MS), as well as systemic inflammatory triggers, could lead
to the anomalous production of inflammatory mediators
at synaptic sites with the subsequent disruption of synap-
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cesses are associated with behavioral and cognitive
changes consisting in fatigue, depression, impaired learn-
ing and memory. These symptoms, all very frequent dur-
ing MS, were collectively named as “sickness behavior”
[6–8]. Specifically, during MS, cognitive impairment is
very common with an important impact on patient’s
daily activities and quality of life [9] and it is detectable
even during the earlier phases of the disease [9, 10]. Be-
havioral and cognitive alterations during MS could rep-
resent the clinical consequences of a subtle synaptic
impairment, derived from an abnormal production of
pro-inflammatory molecules by activated microglia dur-
ing central inflammation [1, 11, 12]. Altered synaptic
plasticity could shape the course of MS. Indeed, the
plastic potential of the central nervous system (CNS) is
fundamental to recover from brain injuries, and the dis-
ruption of the main forms of synaptic plasticity may
exert a negative impact on disease progression and accu-
mulation of disability [13, 14]. Among the various CNS
sites involved in MS, the hippocampus is particularly
vulnerable to the detrimental effects of neuroinflamma-
tion [15, 16]. Several studies demonstrated that hippo-
campal impairment is associated with depression and
cognitive decline, such as verbal and visuo-spatial mem-
ory deficits [17–20]. The aim of the present work is to
review the available evidence about the alteration of hip-
pocampal synaptic plasticity in experimental models of
MS and to discuss their relevance with regard to human
MS.
The hippocampus: structure and function
“The findings reported herein led us to attribute a
special importance to the anterior hippocampus and
hippocampal gyrus in the retention of new experience.”
(Scoville and Milner, 1957) [21].
This sentence was the conclusion reached by Scoville
and Milner during their neurosurgical study in 1957
[21]. In order to treat patients with psychiatric disorders
or untreatable forms of epilepsy, they performed exten-
sive bilateral medial temporal-lobe resections. One of
their patient, H.M., after a bilateral medial temporal lobe
resection, showed a partial retrograde and anterograde
amnesia [21]. Interestingly, his perceptual abilities were
spared, together with his working memory and motor
skill learning. This observation contributed to a large
research field about memory and its anatomical and
biological background. During the last decades, many
neuropsychological, behavioral and neuroimaging studies
pointed to the medial temporal lobe, in particular to the
hippocampus, as the critical cerebral structure for
declarative and spatial memory [22, 23]. In particular,the integrity of human hippocampus is considered fun-
damental for the formation of episodic memory, the
ability to recall personal experiences and semantic
knowledge, that could be considered the basis of per-
sonal learning and culture [22, 23]. This may explain
why an impairment of these cognitive functions appears
early together with a bilateral atrophy of medial tem-
poral lobes during Alzheimer’s disease [22] and why dur-
ing transient global amnesia a bilateral hippocampal
dysfunction occurs [24]. Moreover, the hippocampus
seems to be the core structure encoding visuo-spatial in-
formation, as explained by the cognitive map theory pro-
posed by O’Keefe and Nadel [25, 26]. This theory tries
to explore the functional organization of hippocampus
in rats and other animals, describing a cognitive map lo-
cated in this cerebral structure, with neurons acting as
place cells [25]. Place cells represent the functional units
of this map, selectively increasing their firing rate when
animals explore a determined and unique spatial region,
helping the rodent to orientate itself and leading to the
formation of an allocentric spatial memory [25, 27]. The
importance of the hippocampus in spatial learning is also
confirmed by the evidence that hippocampal volume is
linked to spatial ability in different species of birds and
small mammals [28, 29]. In humans, neuroimaging studies
with structural magnetic resonance imaging (MRI) scans
showed that the posterior hippocampal volume was
increased bilaterally in licensed London taxi drivers,
compared to age-matched controls [30]. This increased
volume can be explained by the extensive training in
spatial navigation made by these workers, as it corre-
lates positively with time spent driving through the
chaotic traffic in the British capital [30]. In conclu-
sion, the hippocampus appears to be fundamental to
answer questions about what, when and where some-
thing takes place and hippocampal involvement has
been correlated to deficits in verbal and visuo-spatial
memory during MS [17, 20, 31].
The hippocampal structure and synaptic plasticity
were studied to assess their relationship with memory
and human behavior. Declarative and episodic memory
can be deconstructed in sequentially organized associa-
tive representations, in which each single event or vari-
able is specifically settled in a unique flow, ultimately
leading to a coherent experience or meaning [23]. Mem-
ory could be seen as a relational network in which each
event correlates with others in a negative or positive
way. Hippocampal structure and synaptic properties
seem to fit perfectly with this functional activity, owing
to its ability to create associations, intensifying some of
them while lowering others [27, 32, 33]. This structure is
well organized to process and associate different kinds
of information, working as a C-shaped computational
loop with extensive recurrent fibers (Fig. 1). A lot of
Fig. 1 Simplified functional anatomy of the hippocampus. Hippocampal circuitry is usually described as a trisynaptic loop, with a C-shaped
organization. Perforant Path (PP) carries the major hippocampal input, consisting in polimodal sensory information collected by the Entorhinal
Cortex (EC) from higher sensory cortices. PP contacts dendritic spines of granule cells in hippocampal Dentate Gyrus (DG), and a smaller part
contacts directly neurons of the CA1 and CA3 hippocampal areas. Axons from DG granule cells are collectively named Mossy Fibres (MF) and
project to hippocampal CA3 pyramidal cells. These cells represent an important computational node, since they are connected to contralateral
CA3 and CA1 pyramidal cells through associational/commissural fibres. Moreover, they receive recurrent connections from ipsilateral CA3 cells,
representing “internal” inputs, and they receive “external” inputs from DG and EC. CA3 pyramidal cells then project to ipsilateral CA1 pyramidal
neurons, with connection fibres named Schaffer Collaterals (SC). Synapses between SC and CA1 neurons, and their plastic modulation, seem to
be crucial for hippocampal computational ability and memory encoding. Lastly, CA1 axons contact directly and indirectly, through Subiculum,
the EC
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converge towards the hippocampus through entorhinal
cortex (EC) and perforant path (PP). PP axons make
excitatory synaptic contact with all the three major areas
of the hippocampus, the dentate gyrus (DG), cornus
ammonis (CA)3 and CA1 areas. In particular, they
contact granule cells located within the DG. These cells
project through the mossy fibres (MF) to CA3 pyramidal
neurons, which in turn send recurrent connections to
other CA3 pyramidal neurons creating a kind of rever-
berant signaling. Thus, CA3 hippocampal area receives
two kinds of information: “external” information from
EC, PP and CA1 area through the MF; “internal” infor-
mation from CA3 pyramidal recurrent connections [34].
Axons from CA3 neurons finally converge into Schaffer
Collaterals (SC) and contact dendrites of CA1 pyramidal
cells, whose projections ultimately contact the subicu-
lum (SUB) and the EC [23, 33, 34]. This circuitry is
extensively modulated by associational and commissural
fibers and by inhibitory neurons distributed in all of the
described hippocampal areas, creating a complex net of
connections.
The plastic modulation of hippocampal synaptic
activity could represent the functional basis of its
computational ability. The simultaneous and repetitive
stimulation of connected sub-components of this assem-
bly, each one representing a specific external or internal
stimulus, could lead to a strengthened connection be-
tween them [23, 33, 34]. Cortico-hippocampal connec-
tions act as an individual guidance to modulate behaviorin relation to the spatial, temporal and semantic context
[27]. Such computational activity could predict upcom-
ing stimuli and events in the environment, expanding its
role from a static representation of reality to a probabil-
istic computational unit, useful to orientate human be-
havior towards a mutating and unexpected reality [27].
Synaptic plasticity, memory and learning in the
hippocampus
“Our experiments show that there exists at least one
group of synapses in the hippocampus whose efficiency
is influenced by activity which may have occurred
several hours previously - a time scale long enough to
be potentially useful for information storage.” (Bliss
and Lomo, 1973) [35]
The way through which a neuronal network can
storage and recall information always attracted neurosci-
entist’s attention. Since the histological structure of the
nervous system was described, several researchers tried
to hypothesize how neural activity can modulate and
influence neuronal connections [36]. In 1949, Donald
Hebb in his book “The organization of behavior” postu-
lated that a connection between two neuronal cells is
strengthened by the simultaneously activation of both of
them [37]. This Hebbian principle is a coincidence-
detection rule, which reflected the long-standing idea,
dating back to Cajal, that repeated stimulation of a
synaptic connection could induce structural synaptic
Mancini et al. Multiple Sclerosis and Demyelinating Disorders  (2017) 2:2 Page 4 of 12changes, as a way to form sustained memory traces from
episodic experiences during learning [38]. Few decades
later, an experimental support to this principle was pro-
vided. Bliss and Lomo demonstrated that repetitive high
frequency stimulation (HFS) of the PP fibers to the DG
of the hippocampus leads to a persistent average in-
crease in the amplitude of the population excitatory
post-synaptic potential (EPSP), meaning a powerful
response of hippocampal granule cells [35]. This effect
was firstly named long-lasting potentiation, successively
best known as long-term potentiation (LTP). To date,
hippocampal LTP is surely the best known activity-
dependent form of synaptic plasticity [39], it is expressed
by excitatory synapses throughout the brain and it appears
to be dependent both on post-synaptic and pre-synaptic
processes [40] (Fig. 2). LTP, together with long-term
depression (LTD) [40, 41] and other forms of synapticFig. 2 Long-term potentiation (LTP) induction. In basal “control” condition,
stimulation interacts with α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic a
excitatory post-synaptic potential (control EPSP). In this condition, glutamate i
no consequence because of the voltage-dependent blockage by magnesium
is mimicked in experimental conditions by the high frequency stimulation (HFS
allowing a Ca2+ influx into the post-synaptic element. This influx leads to the
other several kinases, not shown in the figure, such as protein kinase A (PKA), a
(MAPK), which induce molecular changes in the post-synaptic dendritic spine
conductance, and more AMPA receptors are delivered to the plasma membra
expression is modulated in order to modify the morphology and the molecu
nitric oxide (NO), seem to play a role in LTP induction and maintenance
synaptic modifications ultimately result in a sustained long-term increas
the two neuronsplasticity, represent the most probable physiological basis
of human learning and memory [23, 27, 33, 34], and
several studies showed their occurrence in vivo at synaptic
sites [40, 42].
Long-term forms of synaptic plasticity, such as LTP,
are considered the physiological basis of human mem-
ory, since they are induced rapidly after synaptic stimu-
lation, they are stable over time and can associate
different stimuli in a functional network facilitating the
encoding and recalling of information [42]. To prove
these features of LTP many studies tried to demonstrate
with electrophysiological techniques that it plays an im-
portant functional role in learning and memory. In 1983,
Collingridge and colleagues showed that the selective
blockage of N-methyl-D-aspartate (NMDA) glutamate
receptors with the drug amino-phosphonovaleric acid
(AP5) at excitatory hippocampal synapses, was able toglutamate (Glu) released by the pre-synaptic terminal after an electric
cid (AMPA) glutamate receptor, resulting in sodium (Na+) influx and an
nteraction with N-methyl-D-aspartate (NMDA) glutamate receptors has
(Mg2+) of these receptors. During repetitive synaptic stimulation, which
) protocol, the voltage-dependent NMDA blockage by Mg2+ is removed,
activation of calcium/calmodulin-dependent protein kinase II (CaMKII) and
typical protein kinase C isoforms and mitogen-activated protein kinases
[1, 40]. AMPA receptors are phosphorylated with an increase in Na+
ne from the sub-synaptic compartments. Moreover, neuronal gene
lar structure of the dendritic spine. Finally, retrograde messengers like
, enhancing Glu release from the pre-synaptic element. All these
e of the EPSP (LTP), enhancing excitatory transmission between
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tamate receptor in synaptic plasticity was later supported
by the studies of Morris and colleagues, who studied the
behavioral effects of chronic, in vivo, intraventricular in-
fusion of D,L-AP5 in rats [44]. During their experiments,
rats were located into a large pool of water with a hid-
den platform located at a corner, and they measured the
mean time needed to find the hidden platform and es-
cape from water, a test known as Morris water maze
[44]. The authors showed that the infusion of a selective
NMDA antagonist, capable to block LTP induction
in vitro, caused a significant impairment in learning and
spatial navigation, suggesting a key role for hippocampal
LTP in memory and spatial learning [44]. Whitlock and
colleagues studied hippocampal synaptic alterations
induced by inhibitory avoidance test (IAT), a test cap-
able to induce a rapidly acquired and stable spatial
memory, with associated changes in gene expression
in the CA1 area of hippocampus [42]. They showed
that the molecular changes occurring at hippocampal
synapses during the in vitro induction of LTP, like the
phosphorylation of α-amino-3hydroxy-5methyl-4-isoxa-
zolepropionic acid (AMPA) glutamate receptor GluR1
subunit, where similar to those occurred after a cycle
of active avoidance training, meaning that synapses
responsible of controlling that form of learning
probably expressed LTP [42]. These results support
the hypothesis that spatial learning induces LTP in
the CA1 area of the hippocampus.
In the last years, many studies explored new physio-
logical pathways and cellular types implicated in the
modulation of activity-dependent synaptic plasticity.
Resident glial cells in the CNS, like astrocytes, seem to
be key partners of neurons, actively regulating synaptic
transmission [45]. Interestingly, also microglial cells, the
resident immune cells and phagocytes of CNS, which
rapidly activate in response to brain injury, dynamically
interact with synapses in physiological conditions, acting
like synaptic sensors modulating neuronal excitability
and transmission [3, 46]. To date, synapses appear to be
a more complex anatomical structure than it was
believed before. Synapses are indeed now considered a
“tri-partite” or even a “quad-partite” connection, in
which pre- and post- synaptic neurons interact with glial
cells such as astrocytes or microglia in order to modu-
late the efficacy of synaptic transmission [2, 3, 45–48].
Interestingly, the functional role of glial cells in synaptic
plasticity could be crucial in particular during patho-
logical conditions. For example, the regulation of water
balance in CNS has been reported to be relevant in syn-
aptic plasticity [49]. Aquaporin-4 (AQP4) is a water
channel expressed by astrocytes in CNS and its abnor-
mal modulation during pathologic conditions such as
cerebral edema, epilepsy and ischemia could lead to adefective LTP and LTD at hippocampal synapses [50].
Increasing attention is now oriented towards the func-
tional and structural role of astrocytes in synaptogenesis
and the regulation of synaptic activity [5, 51, 52].
Astrocytes are able to modulate the extracellular
concentration of neurotransmitters, but they can also
influence the expression and functional activity of post-
synaptic receptors [53], helping in the maintenance of
advantageous connections and removal of superfluous
ones. Moreover, neuronal homeostasis, energy metabol-
ism and defense against oxidative stress appear to be
dependent on several astrocytic processes such as
glutamate uptake and recycling, K+ buffering, lactate
release, glycogen mobilization, glutathione (GSH) syn-
thesis and the production of neuroprotective trophic
factors (for example nerve growth factor, NGF, ciliary
neurotrophic factor, CNTF, glial cell-line derived neuro-
trophic factor, GDNF, and fibroblast growth factor 2,
FGF-2) [54]. During neuroinflammatory processes, glial
activation could lead to the release of a wide repertoire
of immune mediators and cytokines, potentially affecting
neuronal viability and synaptic transmission [54]. Indeed,
an astrocyte-derived mediator, such as lactosylceramide,
could play a role in CNS inflammation and neuronal
degeneration in experimental models of MS, interfering
with glutamate transmission [55–57]. Similarly, microglia
is gaining attention as a central regulator of synaptic
transmission during neuroinflammation and other neuro-
degenerative disorders [2, 3, 48, 58].
Microglia, neuroinflammation and synaptic plasticity:
a deep impact
In the CNS, approximately 10% of the total cellular
elements are represented by microglia, with variations
between 0.5 to 16.6% for each human brain area [3, 59].
Microglia is constituted by mesodermal cells which
migrate in the neural tube from the yolk-sac during the
first ten embryonic days [2, 48]. They share the same
lineage with monocytes and macrophages and represent
the main resident immune innate defense within the
CNS, contributing to inflammatory response against
different kind of injuries [3]. Microglia is normally rest-
ing in the mature nervous system, with a phenotype
characterized by long ramified processes extending from
a small cell body [2]. During nervous tissue injury or
inflammatory processes, microglial cells become acti-
vated, shaping into a globular “amoeboid” form with the
ability to move towards the site of damage [3]. Even
when in their “quiescent” or “resting” state, the thin
microglial processes are highly dynamic and continu-
ously scan neighboring neurons transiently contacting
synapses near them with fast movements [60, 61].
Interestingly, microglial thin processes express several
classes of neurotransmitter receptors and ion channels,
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that NMDA receptors expressed by microglia can modu-
late the neuroinflammatory process, influencing reactive
oxygen species (ROS) and cytokines production [62].
This rich equipment in neurotransmitter receptors and
ion channels could be useful in physiological conditions
to sample the extracellular matrix, monitoring neuronal
activity near microglial cells. This function could lead
microglia to play the role of active supervisor of neur-
onal firing activity and synaptic function [2, 48]. The
monitoring activity of microglia seems to be crucial in
the CNS development and refinement during the post-
natal period [47, 63]. Microglia is indeed able to
phagocytize inappropriate exuberant synapses, a process
known as synaptic pruning, and apoptotic neurons, even
by directly inducing programmed cell death through
apoptotic signals [2, 47, 48, 63]. In fact, mice lacking the
receptor for fractalkine (CX3CR1), a molecule which
promotes microglia migration into CNS, show a reduced
microglia brain concentration during CNS development,
in association to an impaired synaptic pruning and syn-
aptic transmission [63]. Parkhurst and colleagues studied
the role of microglia in synaptic plasticity in an animal
model lacking CNS microglia [64]. They generated
CX3CR1(CreER) mice expressing tamoxifen-inducible
Cre recombinase that allows for specific gene function
manipulation in microglia [64]. They induced the ex-
pression of diphtheria toxin receptor in microglia, so
they could later specifically remove microglia from the
brain upon diphtheria toxin administration [64]. They
found that microglia-depleted mice show behavioral
abnormalities associated with hippocampal-dependent
learning impairment. Interestingly, these abnormalities
were associated with abnormal turnover of dendritic
spines, and could be mimicked by the lack of brain-
derived neurotrophic factor (BDNF) [64]. These results
obtained by Parkhurst strongly support the crucial role
played by microglia in neuroplasticity and learning.
Thus, emerging evidence is converging toward a regu-
lating role for microglia on synaptic transmission and
synaptic plasticity in the adult brain. Microglia can
act as modulator by several mechanisms, for example
producing molecules such as interleukin-1β (IL-1β)
and tumor necrosis factor α (TNF-α), which have an
active influence on the main forms of synaptic plasti-
city, learning and memory, both during physiological
and pathological condition [1, 3, 65, 66].
In particular, the effect of IL-1β on synaptic plasti-
city was studied by Katsuki and colleagues, who
showed that recombinant human IL-1β is able to
block the induction of hippocampal LTP in mouse
brain slices [67]. Other research groups confirmed
this evidence, suggesting a key role for this cytokine
in synaptic plasticity defects observed duringneuroinflammatory processes [58, 66, 68–70]. How-
ever, endogenous IL-1β is normally expressed at low
levels in control conditions, and it has been proposed
to be essential for the physiological induction of hip-
pocampal LTP and consolidation of memory [65, 71].
Accordingly, the analysis of a genetic murine model
lacking IL-1β receptor showed impaired hippocampal
neuro-plasticity [72]. The molecular pathway activated
by IL-1β, which involves mitogen activated protein ki-
nases (MAPKs) and nuclear factor-kappa β (NF-κβ),
could indeed influence neuronal gene expression and
regulate plastic processes at synaptic sites [1]. In par-
ticular, the assembly, expression and phosphorylation
of glutamate receptor, glutamate secretion, intra-
cellular calcium concentration, ROS production and
cholinergic neurotransmission are influenced and reg-
ulated by IL-1β [1]. Thus, IL-1β could exert a funda-
mental role in modulating and favoring synaptic
plasticity when expressed at physiological low levels,
while an increased expression of this cytokine, such
as during neuroinflammatory processes, could exert
detrimental effects on neuroplasticity in the hippo-
campus. Interestingly, a recent study assessed the
cerebro-spinal fluid (CSF) levels of this cytokine in
170 patients with relapsing-remitting MS, during
clinical and radiological remission [73]. As result, higher
CSF levels of IL-1β were found to be associated with mid-
term disease progression [73]. This work could support
the hypothesis that an inflammatory environment in the
CNS, potentially leading to the failure of brain plastic
capacities, could play a pathogenic role during disease
progression in patients with MS.
The same observation seems to be true for microglial
cells. Indeed, although their physiological activity is
necessary for neuronal circuit development and function,
when microglia becomes activated by inflammatory
stimuli it is able to disrupt the ability of CNS synapses to
express plasticity. In particular, inflammatory processes,
like those occurring during EAE and MS, alter the fine
balance existing between microglia and synapses/neurons,
leading to excessive secretion of inflammatory
products, such as cytokines and ROS, which could
be harmful for neurons and neuroplastic processes
[1, 3, 74].
Hippocampal synaptic plasticity in experimental models
of MS
The possibility to mimic the complex pathogenic mechan-
ism occurring during human MS still remains very diffi-
cult. The experimental model most frequently utilized to
study human MS is represented by experimental auto-
immune encephalomyelitis (EAE), since it mimics some of
the clinical, immunological and histopathological features
of MS [75]. This model resembles the pathogenesis of MS,
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specific immune response trough subcutaneous injections,
for example, of myelin oligodendrocyte glycoprotein 35–55
(MOG35–55) or a syngeneic spinal cord homogenate
[76, 77]. The characterization of this model led to im-
portant discoveries about the pathogenesis of inflam-
matory demyelination. The study of hippocampal
synaptic plasticity dysfunction occurring during EAE
has been conducted by few laboratories, but it repre-
sents an important acquisition to understand the
course of the disease [13]. Kim Do and colleagues
studied the alteration of hippocampal synaptic plasti-
city during EAE induced in C57/Bl6 mice through
immunization against MOG35–55 [78]. They showed a
synaptic dysfunction in the hippocampal CA1 area,
with a selective impairment in the ability to express
LTP at two different time points post-immunization
(13–16 days and 25–35 days), corresponding approxi-
mately to two disability stages (peak and milder).
Interestingly, even before motor deficits became evi-
dent, mice manifested deficits in spatial learning [78],
an evidence also confirmed by other groups [79] con-
sistent with the hypothesis of a latent hippocampal
dysfunction during the earlier phases of the disease,
just after the beginning of the inflammatory process
induced by the administration of the myelin-specific
immunological trigger. As an attempt to reverse the
observed synaptic deficit, authors fed EAE mice with
a ketogenic diet [78]. Interestingly, the ketogenic diet
was able to ameliorate the LTP impairment during
EAE, in addition to the reduction of CD4+ cells and
microglia/macrophages concentration in the CNS
during active neuroinflammation, with subsequent
reduced production of several pro-inflammatory cyto-
kines (IL-1β, interleukin-6, TNF-α, interleukin-12,
interleukin-17) and ROS [78]. These results support
the hypothesis that some of the soluble products of
inflammation are responsible for the observed hippo-
campal synaptic plasticity deficit during the earlier
phases of the disease. More recently, another research
group demonstrated a hippocampal LTP impairment
in rats affected by EAE, with in vivo electrophysio-
logical recordings [80]. In particular, during the acute
phase of EAE (28 hours after mice obtained a disabil-
ity score of at least 3) the authors described a
suppressed LTP induction, probably related to an in-
creased inhibitory GABA-mediated effect [80].
In our laboratory, we found an impaired LTP induc-
tion in the hippocampal CA1 area both during the acute
inflammatory peak phase of EAE [68] and the later re-
mission phase [58]. As experimental model for MS, we
induced EAE in Biozzi ABH mice, which are particularly
prone to develop autoimmune responses, by the injec-
tion of syngeneic spinal cord homogenate [68]. Thismodel follows a clinical course, reminiscent of relapsing-
remitting MS, with acute phases characterized by detect-
able neurological signs followed by remissions with par-
tial or complete recovery, with a later progressive phase
[76]. During the first acute relapse of EAE, the LTP
impairment was found to be associated with an intense
activation of hippocampal microglia and an increased
hippocampal concentration of IL-1β [68]. Such hippo-
campal synaptic plasticity disruption was associated with
changes in the subunit composition of NMDA glutamate
receptor in the hippocampus, with a reduced expression
of GluN2B-subunit [68]. Several evidences suggested
that GluN2B-subunit containing receptors are more
prone to favor the induction of LTP in comparison to
GluN2A containing ones [81, 82]. These molecular
changes could be related to the known effects of IL-1β
on gene expression, glutamate signaling and synaptic
function [1], ultimately leading to a disruption of hippo-
campal LTP. Interestingly, synaptic impairment in the
CA1 area of the hippocampus was detectable not only
during acute EAE phase, but even in the remission phase
of the experimental disease. We found that after the
resolution of motor deficits, it was still possible to detect
a significant impairment of hippocampal LTP and behav-
ioural abnormalities, suggesting a deficit in spatial mem-
ory during the open field hole-board test [58]. These
abnormalities in remitting EAE mice were associated
with a persistent activation of hippocampal CA1 micro-
glia, an increase in hippocampal IL-1β levels and the
over expression by microglial cells of a ROS producing
enzyme, nicotinamide adenine dinucleotide phosphate
(NADPH) oxidase, as assessed by hippocampal immuno-
histochemistry and Western blot analyses [58]. The
treatment with minocycline, an antibiotic with profound
anti-inflammatory properties, was able to significantly
reduce hippocampal microglia activation, NADPH oxi-
dase expression and IL-1β levels, and to reverse the
previously observed hippocampal LTP impairment and
cognitive deficits in remitting EAE mice [58]. As a fur-
ther support to the role of activated microglia and ROS
producing enzymes, we showed that the application of
apocynin, an inhibitor of NADPH oxidase, was able to
rescue hippocampal LTP deficit during the EAE remis-
sion phase [58]. Moreover, apocynin was also able to
block the detrimental effect of IL-1β on synaptic plasti-
city in control conditions, suggesting an involvement of
NADPH oxidase expression in this process [58]. Thus,
even after the resolution of motor symptoms in remit-
ting EAE mice, persistent hippocampal microglia activa-
tion is associated with the release of inflammatory
mediators, such as IL-1β, and the production of ROS
through NADPH oxidase, and could be responsible of
hippocampal CA1 LTP impairment and related cognitive
deficits in spatial learning during MS [58].
Fig. 3 Neuroinflammation and synaptic impairment. According to
a widely accepted pathogenic model for MS and experimental
autoimmune encephalomyelitis (EAE), autoreactive B and T cells
migrate in the CNS through the blood–brain barrier. At this site,
microglial cells participate in the process of T cells reactivation
presenting CNS antigens in association with MHC class II
molecules. Immune cells trigger the neuroinflammatory process
associated with MS and EAE, with the production of cytokines (such as
IL-1β and TNF-α) and other soluble products of inflammation (such as
ROS) capable to deeply influence neuronal transmission, potentially
leading to the disruption of the main form of synaptic plasticity (LTP).
In this process, microglial activation is associated with an over-
expression of NADPH-oxidase, a ROS producing enzyme, which has
been demonstrated to be relevant for synaptic plasticity impairment
during neuro-inflammatory processes [58]
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early mild phase of MOG35–55 induced EAE (between
days 14 and 19 post immunization), there was no
impairment of hippocampal synaptic plasticity, while in
later phases (between days 40 and 45 post-immunization)
hippocampal LTP and LTP-related memory, such as
spatial memory, were affected [83]. In their experi-
mental setting they used as control group mice
treated with complete Freund’s adjuvant (CFA) alone,
without MOG35–55 [83].
In contrast with the results described above, Nisticò
and colleagues found an enhanced hippocampal LTP
amplitude in slices obtained by EAE mice, with respect
to CFA-treated mice, leading to the hypothesis that the
neuro-inflammatory process associated with EAE could
also potentiate neuroplastic abilities of the CNS [84] in
the utilized experimental setting. This research group
utilized MOG35–55 induced EAE, and they considered as
control group mice treated with an emulsion of CFA.
With this experimental protocol, they also showed that
the ability of EAE in favouring LTP induction was mim-
icked by the exposure of control CFA slices to IL-1β
[84]. Interestingly, during EAE they found a reduced effi-
cacy of inhibitory GABAergic transmission, coupled with
a reduction of hippocampal GABAergic neurons [84].
This effect was mimicked in CFA treated mice slices by
the exposure to IL-1β or IL-1β-activated microglial cells
[84]. Considering this evidence, the authors suggested
that the pathogenic mechanism underlying the enhanced
synaptic plasticity during acute phase of EAE was repre-
sented by a decreased hippocampal inhibitory neuro-
transmission [84]. Finally, another research group
described a normal hippocampal LTP during the course
of EAE. Indeed, Prochnow and colleagues demonstrated
that an LTD impairment could be detected in several
brain regions during the acute phase of MOG35–55
induced EAE, such as the cerebellum and the superior
culliculus [85]. Conversely, they did not find abnormal-
ities of synaptic plasticity in the CA1 area of the hippo-
campus, with a normal expression of LTP and LTD [85].
In conclusion, hippocampal long-term synaptic plasti-
city during experimental MS has been studied by several
research groups with partially contrasting results [13].
The majority of the studies found a reduction of the
synapse’s ability to express LTP, but reports also describe
a normal and even an enhanced LTP during the course
of EAE. Unfortunately, the existing differences in experi-
mental models (animal used, modality of EAE induction,
CFA treated or untreated mice as control group) and
electrophysiological protocols (time points after EAE in-
duction, specific electrophysiological technique, stimula-
tion protocols, clinical severity of EAE symptoms)
interfere with the interpretation and comparison of the
studies [13]. However, it appears clear that during CNSinflammation there is significant alteration of the neur-
onal ability to express the main forms of synaptic plasti-
city, probably due to the effect of activated microglia
and soluble products of inflammation (Fig. 3). These
abnormalities in synaptic plasticity could be a dynamic
process, influenced by the severity of inflammation and
the stage of the disease, underlying a progressive func-
tional failure of the brain plastic reserve, possibly con-
tributing to disability progression during human disease.
In line with this hypothesis, the ability to express synap-
tic plasticity has been proposed as a critical factor coun-
teracting disability progression in MS [86]. Mori and
colleagues showed that an altered brain ability to express
LTP is associated with incomplete symptom recovery
after an acute relapse and accumulation of disability
[87]. Interestingly, the same group also demonstrated
that the ability to express LTP, explored by transcranial
magnetic stimulation (TMS) over the primary motor
cortex, was still possible in stable relapsing-remitting
MS patients, while it was absent in primary progressive
MS suggesting that the brain plastic reserve might be
crucial to contrast clinical deterioration in MS [88].
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Different histological studies demonstrated that hippo-
campus is extensively involved during MS, since hippo-
campal demyelination has been detected in 53% to 79%
of post-mortem MS brains [15]. Interestingly, Dutta and
colleagues showed that hippocampal demyelination is
associated with a pronounced decrease in synaptic dens-
ity, with minimal neuronal loss, and an altered neuronal
expression of genes involved in synaptic plasticity,
axonal transport and memory/learning, such as glutam-
ate receptors [16]. This synaptic pauperization could
contribute to cognitive dysfunction [16]. During last
years, neuroimaging studies showed that hippocampal
atrophy is associated with memory dysfunction and de-
pression [18, 29, 89]. In particular, a recent multicentre
study used several structural MRI modalities to assess
how the involvement of different brain regions links to
the specific cognitive deficit suffered by the patient [89].
The authors found that atrophy of left postcentral gyrus
and right hippocampus represents one of the best MRI
findings useful to discriminate between patients with
cognitive deficits and patients cognitively preserved [89].
Together with structural studies, functional MRI
highlighted the key role played by the hippocampus in
cognitively impaired patients. Hulst and colleagues in-
vestigated functional hippocampal activation and its
connectivity during specific memory tasks in cognitively
preserved and cognitively impaired MS patients [90].
They found that, in addition to a decreased hippocampal
volume, patients with memory impairment show a
decreased activation of the right hippocampus and an
increased functional connectivity of the left hippocam-
pus, mostly in connection with right posterior cingulate
region, during cognitive performance [90]. Hippocampus
and posterior cingulate region are both included in brain
default mode network (DMN), a medial cortical network
which has been demonstrated to be impaired during
Alzheimer’s disease [91, 92]. Interestingly, an increased
connectivity between the hippocampus and other brain
structures involved in the DMN was linked to cognitive
impairment during MS [93]. Hulst and colleagues hy-
pothesized that the increased functional connectivity
could represent a maladaptive response of the memory
functional pathway to the accumulating damage occur-
ring during MS, possibly related to the disinhibition of
the entire DMN [90]. In fact, white matter lesions dis-
seminated throughout the brain could impair functional
connectivity between the hippocampus and other brain
regions located in the frontal, temporal, parietal lobe
and cingulate cortex, ultimately leading to a disconnec-
tion syndrome when the compensatory hippocampal
circuitries fail. This was the hypothesis raised by Rocca
and colleagues, who showed a strong correlation be-
tween a high brain T2 lesion volume, reducedhippocampal resting-state functional connectivity, de-
pressive symptoms and clinical disability in MS patients
[17]. A recent study characterized the relationship exist-
ing among neuro-inflammation, hippocampal functional
connectivity and depressive symptoms during MS, by
using positron emission tomography (PET) and func-
tional MRI [94]. The authors measured hippocampal
microglia activation in patients with MS using the 18-
kDa translocator protein (TSPO) radio ligand [18 F]
PBR111, the Beck Depression Inventory (BDI) to assess
depressive symptoms, and resting-state functional MRI
to study hippocampal functional connectivity [94]. As
results, the authors found that intense microglial activa-
tion within the hippocampus was correlated with a re-
duced hippocampal connectivity and severe depression
[94]. Moreover, another research group recently quanti-
fied the presence of activated macrophages/microglia
with simultaneous MR-PET imaging, using the TSPO
radio ligand 11C-PBR28, in patients with both relapsing-
remitting and secondary progressive MS [95]. Relative to
controls, MS subjects exhibited abnormally high brain
11C-PBR28 binding, the greatest increases being in cor-
tex and cortical lesions, thalamus, hippocampus, and
normally appearing white matter (NAWM) [95]. Inter-
estingly, the authors found that microglia/macrophages
activation correlated with reduced cognitive perfor-
mances in the investigated cohort. Specifically, increased
TSPO levels in the hippocampus, as well as in the thal-
amus and NAWM were associated with impaired
Symbol Digit Modalities Test (SDMT) performances, a
measure of information-processing speed [95].
In conclusion, all these studies showed that the
hippocampus could be directly and indirectly affected
by inflammation/demyelination with a subsequent al-
teration of synaptic density and neuronal transmis-
sion. Moreover, also demyelinating lesions spreading
throughout the brain could indirectly determine a dis-
connection syndrome, affecting normal hippocampal
functional connectivity, both during resting condition
and memory tasks. Neuro-inflammation, and in par-
ticular microglial activation, could contribute to alter
normal hippocampal connectivity with other key brain
regions involved in the maintenance of a normal
affective state and cognition [94, 95].
Conclusions
During the last decades, many studies explored the pres-
ence of structural and functional hippocampal changes
and their characteristics during neuro-inflammatory pro-
cesses. A reduction of hippocampal volume was found
to be associated to cognitive deficits involving informa-
tion processing speed and visuo-spatial, verbal and epi-
sodic memory during MS [96]. It has been suggested
that hippocampal impairment could take place early
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demyelinating lesions [31]. Indeed, a selective bilateral
hippocampal CA1 atrophy, exceeding global brain vol-
ume loss, was found in patients with relapsing-remitting
MS independently from T2-lesion volumes, in associ-
ation with deficits in memory encoding, but not in the
speed of information processing, as assessed with word-
list learning test and paced auditory serial addition task
(PASAT) [31]. In this scenario, functional hippocampal
synaptic plasticity impairment could play a fundamental
role in cognitive deficits and symptoms progression dur-
ing MS. Electrophysiological analysis of synaptic trans-
mission in experimental models of MS showed that
hippocampal synaptic plasticity is altered during CNS
inflammation, probably due to the activation of micro-
glia and the release of soluble inflammatory products,
worsening the performances in hippocampal-related
behavioral tests [13]. Accordingly, the presence of active
inflammation, represented by isolated gadolinium en-
hancing lesions at brain MRI, was demonstrated to be
associated with poorer cognitive performances in MS
patients [97]. An altered synaptic plasticity could affect
hippocampal functional connectivity, worsening the
disconnection syndrome associated with demyelination
and synaptic loss within the hippocampus. In conclu-
sion, the hippocampus emerges as a structure particu-
larly vulnerable to injury during neuro-inflammatory
processes. It is affected early during the course of the
disease, as assessed by several studies on both experi-
mental animal models of MS and patients suffering with
MS. A better understanding of the pathogenic process
leading to this selective structural and functional hippo-
campal impairment appears fundamental to imagine
new therapeutic approaches, targeted to preserve cogni-
tive functions and quality of life in people with MS.Abbreviations
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